Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Car+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA

Car+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA

US Patent 11344577 · Granted May 31, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Human application of engineered chimeric antigen receptor (CAR) T-cells2023
Human application of engineered chimeric antigen receptor (CAR) T-cells2023
T-cell receptor (TCR)-binding antibodies and uses thereof2023
Selection methods for genetically-modified T cells2020
Chimeric antigen receptors (CAR) to selectively target protein complexes2020
CAR+ T cells genetically modified to eliminate expression of T-cell receptor and2019
CAR+ T cells genetically modified to eliminate expression of T-cell receptor and2019
Polyclonal gamma delta T cells for immunotherapy2018
Anti-CD19 scFv (FMC63) polypeptide2017
Human application of engineered chimeric antigen receptor (CAR) T-cells2017
Human application of engineered chimeric antigen receptor (CAR) T-cells2017